SBIR-STTR Award

402 - Rfp: N43-Cm-87007-68 Topic 251: Development Of Anticancer Agents Reques
Award last edited on: 2/4/14

Sponsored Program
SBIR
Awarding Agency
NIH
Total Award Amount
$170,367
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Baigen Mei

Company Information

Quintessence Biosciences Inc (AKA: QBI Life Sciences)

505 South Rosa Road
Madison, WI 53719
   (608) 441-2950
   info@quintbio.com
   www.quintbio.com
Location: Single
Congr. District: 02
County: Dane

Phase I

Contract Number: 261200800028C-0-0-1
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2008
Phase I Amount
$170,367
The aim of this project is to develop a novel ribonuclease for the treatment of cancer. The molecule will be modified using polyethylene glycol in order to achieve the desired properties.

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----